Met Life Investment Management, LLC Chroma Dex Corp. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 18,114 shares of CDXC stock, worth $99,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,114
Previous 12,999
39.35%
Holding current value
$99,445
Previous $35,000
88.57%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CDXC
# of Institutions
94Shares Held
17.2MCall Options Held
66.7KPut Options Held
8.2K-
Vanguard Group Inc Valley Forge, PA3.43MShares$18.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$17.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$16.2 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.12 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.31 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $375M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...